Abstract:This review highlights recent advances in renal cell carcinoma (RCC) imaging. It begins with dual-energy computed tomography (DECT), which has demonstrated a high diagnostic accuracy in the evaluation of renal masses. Several studies have suggested the potential benefits of iodine quantification, particularly for distinguishing low-attenuation, true enhancing solid masses from hyperdense cysts. By determining whether or not a renal mass is present, DECT could avoid the need for additional imaging studies, thereby reducing healthcare costs. DECT can also provide virtual unenhanced images, helping to reduce radiation exposure. The review then provides an update focusing on the advantages of multiparametric magnetic resonance (MR) imaging performance in the histological subtyping of RCC and in the differentiation of benign from malignant renal masses. A proposed standardized stepwise reading of images helps to identify clear cell RCC and papillary RCC with a high accuracy. Contrast-enhanced ultrasound may represent a promising diagnostic tool for the characterization of solid and cystic renal masses. Several combined pharmaceutical imaging strategies using both sestamibi and PSMA offer new opportunities in the diagnosis and staging of RCC, but their role in risk stratification needs to be evaluated. Although radiomics and tumor texture analysis are hampered by poor reproducibility and need standardization, they show promise in identifying new biomarkers for predicting tumor histology, clinical outcomes, overall survival, and the response to therapy. They have a wide range of potential applications but are still in the research phase. Artificial intelligence (AI) has shown encouraging results in tumor classification, grade, and prognosis. It is expected to play an important role in assessing the treatment response and advancing personalized medicine. The review then focuses on recently updated algorithms and guidelines. The Bosniak classification version 2019 incorporates MRI, precisely defines previously vague imaging terms, and allows a greater proportion of masses to be placed in lower-risk classes. Recent studies have reported an improved specificity of the higher-risk categories and better inter-reader agreement. The clear cell likelihood score, which adds standardization to the characterization of solid renal masses on MRI, has been validated in recent studies with high interobserver agreement. Finally, the review discusses the key imaging implications of the 2017 AUA guidelines for renal masses and localized renal cancer.

Predominantly multiple focal non-cystic renal lesions: an imaging approach

Diagnostic Assessment and Radiomics

Imaging Manifestations of Acute and Chronic Renal Infection That Mimics Malignancy: How to Make the Diagnosis Using Computed Tomography and Magnetic Resonance Imaging

Imaging in Renal Cell Carcinoma Detection

Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches

Contrast enhanced ultrasound of cystic renal lesions, from diagnosis up to treatment

Molecular imaging for non-invasive risk stratification of renal masses

Contrast-Enhanced Ultrasound as a Diagnostic Procedure in Renal Diseases: A Case Report

Imaging features of adrenal masses

Research in Pathology, Clinical and Imaging Diagnosis of Multilocular Cystic Renal Cell Carcinoma

Multifocal lesions in a kidney allograft

Contrast-enhanced ultrasound in renal cystic lesions: an update

Layer upon layer: Imaging techniques of bladder matrix stone: A case report

Focus on Upper Urinary Tract Stones Combined With Parenchymal Infiltrative Renal Pelvis Cancer

Expanding the Role of Ultrasound for the Characterization of Renal Masses

Neoplastic and Non-neoplastic Bone Lesions of the Knee

Focal Benign Liver Lesions and Their Diagnostic Pitfalls

The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology

Contrast-enhanced ultrasound for characterizing renal masses

CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesions

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review